Literature DB >> 18554524

Cyclic phosphatidic acid - a unique bioactive phospholipid.

Yuko Fujiwara1.   

Abstract

Cyclic phosphatidic acid (CPA) is a naturally occurring analog of the growth factor-like phospholipid mediator, lysophosphatidic acid (LPA). The sn-2 hydroxy group of CPA forms a 5-membered ring with the sn-3 phosphate. CPA affects numerous cellular functions, including anti-mitogenic regulation of the cell cycle, induction of stress fiber formation, inhibition of tumor cell invasion and metastasis, and regulation of differentiation and survival of neuronal cells. Interestingly, many of these cellular responses caused by CPA oppose those of LPA despite the activation of apparently overlapping receptor populations. Since the early 1990s, studies on CPA actions gradually developed, and we are now beginning to understand the importance of this lipid. In this review, we focus on the current knowledge about CPA, including enzymatic formation of CPA, unique biological activities and biological targets of CPA, and we also explore metabolically stabilized CPA analogs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18554524      PMCID: PMC2572151          DOI: 10.1016/j.bbalip.2008.05.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  59 in total

Review 1.  Role of cyclic nucleotides in growth control.

Authors:  I H Pastan; G S Johnson; W B Anderson
Journal:  Annu Rev Biochem       Date:  1975       Impact factor: 23.643

2.  GPR92 as a new G12/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5.

Authors:  Chang-Wook Lee; Richard Rivera; Shannon Gardell; Adrienne E Dubin; Jerold Chun
Journal:  J Biol Chem       Date:  2006-06-14       Impact factor: 5.157

3.  Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate.

Authors:  Laurens A van Meeteren; Paula Ruurs; Evangelos Christodoulou; James W Goding; Hideo Takakusa; Kazuya Kikuchi; Anastassis Perrakis; Tetsuo Nagano; Wouter H Moolenaar
Journal:  J Biol Chem       Date:  2005-03-15       Impact factor: 5.157

4.  Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species. Structure-activity relationship of cloned LPA receptors.

Authors:  K Bandoh; J Aoki; A Taira; M Tsujimoto; H Arai; K Inoue
Journal:  FEBS Lett       Date:  2000-07-28       Impact factor: 4.124

5.  Cyclic phosphatidic acid inhibits RhoA-mediated autophosphorylation of FAK at Tyr-397 and subsequent tumor-cell invasion.

Authors:  Mutsuko Mukai; Teruo Iwasaki; Masaharu Tatsuta; Atsushi Togawa; Hiroyuki Nakamura; Kimiko Murakami-Murofushi; Susumu Kobayashi; Fumio Imamura; Masahiro Inoue
Journal:  Int J Oncol       Date:  2003-06       Impact factor: 5.650

6.  Induction of in vitro tumor cell invasion of cellular monolayers by lysophosphatidic acid or phospholipase D.

Authors:  F Imamura; T Horai; M Mukai; K Shinkai; M Sawada; H Akedo
Journal:  Biochem Biophys Res Commun       Date:  1993-06-15       Impact factor: 3.575

7.  Virtual screening approaches for the identification of non-lipid autotaxin inhibitors.

Authors:  Abby L Parrill; Uniqua Echols; Tran Nguyen; Truc-Chi T Pham; Adrienne Hoeglund; Daniel L Baker
Journal:  Bioorg Med Chem       Date:  2007-11-12       Impact factor: 3.641

8.  Naturally occurring analogs of lysophosphatidic acid elicit different cellular responses through selective activation of multiple receptor subtypes.

Authors:  D J Fischer; K Liliom; Z Guo; N Nusser; T Virág; K Murakami-Murofushi; S Kobayashi; J R Erickson; G Sun; D D Miller; G Tigyi
Journal:  Mol Pharmacol       Date:  1998-12       Impact factor: 4.436

9.  Selective inhibition of DNA polymerase-alpha family with chemically synthesized derivatives of PHYLPA, a unique Physarum lysophosphatidic acid.

Authors:  K Murakami-Murofushi; S Kobayashi; K Onimura; M Matsumoto; M Shioda; S Yoshida; M Shoji; H Murofushi
Journal:  Biochim Biophys Acta       Date:  1995-08-24

10.  Xenopus oocytes express multiple receptors for LPA-like lipid mediators.

Authors:  K Liliom; K Murakami-Murofushi; S Kobayashi; H Murofushi; G Tigyi
Journal:  Am J Physiol       Date:  1996-03
View more
  29 in total

Review 1.  Nuclear sphingolipid metabolism.

Authors:  Natasha C Lucki; Marion B Sewer
Journal:  Annu Rev Physiol       Date:  2011-09-09       Impact factor: 19.318

2.  Synthesis and pharmacological evaluation of the stereoisomers of 3-carba cyclic-phosphatidic acid.

Authors:  Renuka Gupte; Anjaih Siddam; Yan Lu; Wei Li; Yuko Fujiwara; Nattapon Panupinthu; Truc-Chi Pham; Daniel L Baker; Abby L Parrill; Mari Gotoh; Kimiko Murakami-Murofushi; Susumu Kobayashi; Gordon B Mills; Gabor Tigyi; Duane D Miller
Journal:  Bioorg Med Chem Lett       Date:  2010-10-08       Impact factor: 2.823

Review 3.  Cellular function and molecular structure of ecto-nucleotidases.

Authors:  Herbert Zimmermann; Matthias Zebisch; Norbert Sträter
Journal:  Purinergic Signal       Date:  2012-05-04       Impact factor: 3.765

4.  Age-related changes in cyclic phosphatidic acid-induced hyaluronic acid synthesis in human fibroblasts.

Authors:  Katsura Sano; Mari Gotoh; Kyoko Dodo; Noriaki Tajima; Yoshibumi Shimizu; Kimiko Murakami-Murofushi
Journal:  Hum Cell       Date:  2017-10-23       Impact factor: 4.174

Review 5.  Aiming drug discovery at lysophosphatidic acid targets.

Authors:  Gabor Tigyi
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

Review 6.  Lysophosphatidic acid in atherosclerotic diseases.

Authors:  Andreas Schober; Wolfgang Siess
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

7.  Autotaxin: its role in biology of melanoma cells and as a pharmacological target.

Authors:  Maciej Jankowski
Journal:  Enzyme Res       Date:  2011-03-08

8.  Protection of neuroblastoma Neuro2A cells from hypoxia-induced apoptosis by cyclic phosphatidic acid (cPA).

Authors:  Mari Gotoh; Katsura Sano-Maeda; Hiromu Murofushi; Kimiko Murakami-Murofushi
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

9.  PPAR γ Networks in Cell Signaling: Update and Impact of Cyclic Phosphatidic Acid.

Authors:  Tamotsu Tsukahara
Journal:  J Lipids       Date:  2013-02-07

10.  Release of cyclic phosphatidic acid from gelatin-based hydrogels inhibit colon cancer cell growth and migration.

Authors:  Tamotsu Tsukahara; Kimiko Murakami-Murofushi
Journal:  Sci Rep       Date:  2012-09-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.